Literature DB >> 25385798

Role of dendritic cells in the pathogenesis of Whipple's disease.

Katina Schinnerling1, Anika Geelhaar-Karsch1, Kristina Allers1, Julian Friebel1, Kristina Conrad1, Christoph Loddenkemper2, Anja A Kühl1, Ulrike Erben1, Ralf Ignatius3, Verena Moos4, Thomas Schneider1.   

Abstract

Accumulation of Tropheryma whipplei-stuffed macrophages in the duodenum, impaired T. whipplei-specific Th1 responses, and weak secretion of interleukin-12 (IL-12) are hallmarks of classical Whipple's disease (CWD). This study addresses dendritic cell (DC) functionality during CWD. We documented composition, distribution, and functionality of DC ex vivo or after in vitro maturation by fluorescence-activated cell sorting (FACS) and by immunohistochemistry in situ. A decrease in peripheral DC of untreated CWD patients compared to healthy donors was due to reduced CD11c(high) myeloid DC (M-DC). Decreased maturation markers CD83, CD86, and CCR7, as well as low IL-12 production in response to stimulation, disclosed an immature M-DC phenotype. In vitro-generated monocyte-derived DC from CWD patients showed normal maturation and T cell-stimulatory capacity under proinflammatory conditions but produced less IL-12 and failed to activate T. whipplei-specific Th1 cells. In duodenal and lymphoid tissues, T. whipplei was found within immature DC-SIGN(+) DC. DC and proliferating lymphocytes were reduced in lymph nodes of CWD patients compared to levels in controls. Our results indicate that dysfunctional IL-12 production by DC provides suboptimal conditions for priming of T. whipplei-specific T cells during CWD and that immature DC carrying T. whipplei contribute to the dissemination of the bacterium.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25385798      PMCID: PMC4294246          DOI: 10.1128/IAI.02463-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Genome-based design of a cell-free culture medium for Tropheryma whipplei.

Authors:  Patricia Renesto; Nicolas Crapoulet; Hiroyuki Ogata; Bernard La Scola; Guy Vestris; Jean-Michel Claverie; Didier Raoult
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

Review 2.  Dendritic cells: the host Achille's heel for mucosal pathogens?

Authors:  Florence Niedergang; Arnaud Didierlaurent; Jean-Pierre Kraehenbuhl; Jean-Claude Sirard
Journal:  Trends Microbiol       Date:  2004-02       Impact factor: 17.079

3.  Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease.

Authors:  T Marth; M Neurath; B A Cuccherini; W Strober
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

Review 4.  The sensitization phase of T-cell-mediated immunity.

Authors:  R M Steinman; S Koide; M Witmer; M Crowley; N Bhardwaj; P Freudenthal; J Young; K Inaba
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  IL-16 is critical for Tropheryma whipplei replication in Whipple's disease.

Authors:  Benoît Desnues; Didier Raoult; Jean-Louis Mege
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.

Authors:  Tatsuya Kanto; Michiyo Inoue; Hideki Miyatake; Aki Sato; Mitsuru Sakakibara; Takayuki Yakushijin; Chika Oki; Ichiyo Itose; Naoki Hiramatsu; Tetsuo Takehara; Akinori Kasahara; Norio Hayashi
Journal:  J Infect Dis       Date:  2004-10-27       Impact factor: 5.226

7.  Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.

Authors:  D C Baumgart; D Metzke; J Schmitz; A Scheffold; A Sturm; B Wiedenmann; A U Dignass
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.

Authors:  F Ria; G Penna; L Adorini
Journal:  Eur J Immunol       Date:  1998-06       Impact factor: 5.532

9.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.

Authors:  Angela Granelli-Piperno; Angelika Golebiowska; Christine Trumpfheller; Frederick P Siegal; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

10.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

Authors:  M Cella; D Scheidegger; K Palmer-Lehmann; P Lane; A Lanzavecchia; G Alber
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  8 in total

1.  Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Authors:  Kathleen Weigt; Alexandra Wiessner; Annette Moter; Florence Fenollar; Didier Raoult; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 2.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.

Authors:  Lucia Trotta; Kathleen Weigt; Katina Schinnerling; Anika Geelhaar-Karsch; Gerrit Oelkers; Federico Biagi; Gino Roberto Corazza; Kristina Allers; Thomas Schneider; Ulrike Erben; Verena Moos
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

4.  Architectural and functional alterations of the small intestinal mucosa in classical Whipple's disease.

Authors:  H-J Epple; J Friebel; V Moos; H Troeger; S M Krug; K Allers; K Schinnerling; A Fromm; B Siegmund; M Fromm; J D Schulzke; T Schneider
Journal:  Mucosal Immunol       Date:  2017-02-08       Impact factor: 7.313

5.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

6.  Intestinal barrier dysfunction mediates Whipple's disease immune reconstitution inflammatory syndrome (IRIS).

Authors:  Julian Friebel; Katina Schinnerling; Anika Geelhaar-Karsch; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Immun Inflamm Dis       Date:  2022-05

7.  Whipple's disease: a fatal mimic.

Authors:  Benjamin Kukull; Jonathon Mahlow; Gillian Hale; Lindsey J Perry
Journal:  Autops Case Rep       Date:  2021-01-28

8.  Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis.

Authors:  Asma Boumaza; Soraya Mezouar; Matthieu Bardou; Didier Raoult; Jean-Louis Mège; Benoit Desnues
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.